Literature DB >> 19320739

Frontiers and controversies in the pathobiology of vitiligo: separating the wheat from the chaff.

Raymond E Boissy1, Richard A Spritz.   

Abstract

The pathogenesis of vitiligo is complex and not well understood. Genes play a role in all aspects of vitiligo pathogenesis, and studies are ongoing to identify these genes and understand their biology. There is a body of interlocking, compelling evidence supporting an autoimmune basis for most or all cases of generalized vitiligo. The development of an autoimmune disease generally involves three components; the immune system, environmental triggers and other exogenous precipitating factors, and the target tissue. In vitiligo, precipitating factors could induce melanocyte damage in genetically susceptible individuals and consequent cell death, loss of tolerance, and induction of melanocyte-directed autoimmunity. Future research will more precisely define the multiple biological events that regulate development of vitiligo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19320739      PMCID: PMC2745236          DOI: 10.1111/j.1600-0625.2008.00826.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  18 in total

1.  Adoptive transfer of vitiligo after allogeneic bone marrow transplantation for non-Hodgkin's lymphoma.

Authors:  P Neumeister; D Strunk; U Apfelbeck; H Sill; W Linkesch
Journal:  Lancet       Date:  2000-04-15       Impact factor: 79.321

2.  Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families.

Authors:  Asem Alkhateeb; Pamela R Fain; Anthony Thody; Dorothy C Bennett; Richard A Spritz
Journal:  Pigment Cell Res       Date:  2003-06

Review 3.  A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?

Authors:  Yvon Gauthier; Muriel Cario Andre; Alain Taïeb
Journal:  Pigment Cell Res       Date:  2003-08

4.  Assessing the impact of population stratification on genetic association studies.

Authors:  Matthew L Freedman; David Reich; Kathryn L Penney; Gavin J McDonald; Andre A Mignault; Nick Patterson; Stacey B Gabriel; Eric J Topol; Jordan W Smoller; Carlos N Pato; Michele T Pato; Tracey L Petryshen; Laurence N Kolonel; Eric S Lander; Pamela Sklar; Brian Henderson; Joel N Hirschhorn; David Altshuler
Journal:  Nat Genet       Date:  2004-03-28       Impact factor: 38.330

5.  4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo.

Authors:  Tara M Kroll; Hemamalini Bommiasamy; Raymond E Boissy; Claudia Hernandez; Brian J Nickoloff; Ruben Mestril; I Caroline Le Poole
Journal:  J Invest Dermatol       Date:  2005-04       Impact factor: 8.551

Review 6.  Human pigmentation genes and their response to solar UV radiation.

Authors:  R A Sturm
Journal:  Mutat Res       Date:  1998-11-09       Impact factor: 2.433

7.  Transfer of vitiligo after allogeneic bone marrow transplantation.

Authors:  Abdulmajeed Alajlan; Abdullah Alfadley; Kristian-Thestrup Pedersen
Journal:  J Am Acad Dermatol       Date:  2002-04       Impact factor: 11.527

Review 8.  Evidence for an autoimmune pathogenesis of vitiligo.

Authors:  Katia Ongenae; Nanny Van Geel; Jean-Marie Naeyaert
Journal:  Pigment Cell Res       Date:  2003-04

9.  Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.

Authors:  B J Marshall; J R Warren
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

10.  Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo.

Authors:  Greggory Laberge; Christina M Mailloux; Katherine Gowan; Paulene Holland; Dorothy C Bennett; Pamela R Fain; Richard A Spritz
Journal:  Pigment Cell Res       Date:  2005-08
View more
  19 in total

Review 1.  Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease.

Authors:  Richard A Spritz
Journal:  Thyroid       Date:  2010-07       Impact factor: 6.568

Review 2.  Highlights in pathogenesis of vitiligo.

Authors:  Ghada F Mohammed; Amal Ha Gomaa; Mohammed Saleh Al-Dhubaibi
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

3.  Association study between polymorphisms of CD28, CTLA4 and ICOS and non-segmental vitiligo in a Korean population.

Authors:  Min Kyung Shin; So Hee Im; Hae Jeong Park; Su Kang Kim; Sung Vin Yim; Joo-Ho Chung; Mu-Hyoung Lee
Journal:  Exp Ther Med       Date:  2011-08-03       Impact factor: 2.447

4.  Clinical characteristics and PTPN22 1858C/T variant analysis in Jordanian Arab vitiligo patients.

Authors:  Asem Alkhateeb; Firas Qarqaz; Jude Al-Sabah; Tasnim Al Rashaideh
Journal:  Mol Diagn Ther       Date:  2010-06-01       Impact factor: 4.074

Review 5.  Recent progress in the genetics of generalized vitiligo.

Authors:  Richard A Spritz
Journal:  J Genet Genomics       Date:  2011-06-12       Impact factor: 4.275

6.  A Rare Case of Congenital Vitiligo in a Neonate.

Authors:  Purva Pande; Sree Ramu Suggu; Mala Bhalla
Journal:  J Clin Aesthet Dermatol       Date:  2021-06-01

7.  Genome-wide association study of generalized vitiligo in an isolated European founder population identifies SMOC2, in close proximity to IDDM8.

Authors:  Stanca A Birlea; Katherine Gowan; Pamela R Fain; Richard A Spritz
Journal:  J Invest Dermatol       Date:  2009-11-05       Impact factor: 8.551

Review 8.  Six decades of vitiligo genetics: genome-wide studies provide insights into autoimmune pathogenesis.

Authors:  Richard A Spritz
Journal:  J Invest Dermatol       Date:  2011-10-13       Impact factor: 8.551

9.  Hypothesis: zinc can be effective in treatment of vitiligo.

Authors:  Nooshin Bagherani; Reza Yaghoobi; Mohammad Omidian
Journal:  Indian J Dermatol       Date:  2011 Sep-Oct       Impact factor: 1.494

10.  Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin.

Authors:  Richard Yu; Raewyn Broady; Yuanshen Huang; Yang Wang; Jie Yu; Min Gao; Megan Levings; Shencai Wei; Shengquan Zhang; Aie Xu; Mingwan Su; Jan Dutz; Xuejun Zhang; Youwen Zhou
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.